ImmunoCure

医克生物

ImmunoCure

Materials/Deep Tech

Beijing Yike Biopharmaceutical Co., Ltd. is a biotechnology group focused on the PD-1-enhanced nucleic acid vaccine and anti-Δ42PD1 antibody technology platforms invented and patented by the AIDS Institute of the University of Hong Kong.

Latest round: Series A (2023)

Source: ChinaBulls — chinabulls.com

Last updated 2023-07-01